Jonathan F. Tait

Overview

Best Publications

• Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

  Jason D. Arroyo;John R. Chevillet;Evan M. Kroh;Ingrid K. Ruf

  4349
  Citations

• Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies.

  Colin C. Pritchard;Evan Kroh;Brent Wood;Jason D. Arroyo

  1191
  Citations

• Apoptotic vascular endothelial cells become procoagulant

  Thomas Bombeli;Aly Karsan;Jonathan F. Tait;John M. Harlan

  858
  Citations

• Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

  Mary Claire King;Sam Wieand;Kathryn Hale;Ming Lee

  802
  Citations

• In vivo detection and imaging of phosphatidylserine expression during programmed cell death

  F G Blankenberg;P D Katsikis;J F Tait;R E Davis

  750
  Citations

• Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations

  Brent L. Wood;Donald F. Gibson;Jonathan F. Tait

  651
  Citations

• Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets.

  P Thiagarajan;J F Tait

  470
  Citations

• Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family.

  J F Tait;D Gibson;K Fujikawa

  447
  Citations

• Plasma processing conditions substantially influence circulating microRNA biomarker levels.

  Heather H. Cheng;Hye Son Yi;Yeonju Kim;Evan M. Kroh

  358
  Citations

• Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

  Colin C. Pritchard;Stephen J. Salipante;Karen Koehler;Christina Smith

  353
  Citations

• Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.

  Eyk A. Schellenberger;Alexei Bogdanov;Dagmar Högemann;Jonathan Tait

  308
  Citations

• Imaging of Apoptosis (Programmed Cell Death) with 99mTc Annexin V

  Francis G. Blankenberg;Peter D. Katsikis;Jonathan F. Tait;Richard Eric Davis

  301
  Citations

• Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

  Colin C. Pritchard;Colm Morrissey;Akash Kumar;Xiaotun Zhang

  283
  Citations

• Placental anticoagulant proteins: isolation and comparative characterization of four members of the lipocortin family

  Jonathan F. Tait;Mitsuhiko Sakata;Brad A. McMullen;Carol H. Miao

  272
  Citations

• Binding and Phagocytosis of Apoptotic Vascular Smooth Muscle Cells Is Mediated in Part by Exposure of Phosphatidylserine

  M.R. Bennett;D.F. Gibson;S.M. Schwartz;J.F. Tait

  267
  Citations

• Evaluation of 18F-Annexin V as a PET Imaging Agent in an Animal Model of Apoptosis

  Kevin J. Yagle;Janet F. Eary;Jonathan F. Tait;John R. Grierson

  228
  Citations

• Phospholipid binding of annexin V: Effects of calcium and membrane phosphatidylserine content

  Jonathan F. Tait;Donald Gibson

  227
  Citations

• Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding.

  J F Tait;D Gibson

  221
  Citations

• ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing

  Colin C. Pritchard;Christina Smith;Stephen J. Salipante;Ming K. Lee

  221
  Citations

• 18F-labelled annexin V: a PET tracer for apoptosis imaging.

  Yoshihiro Murakami;Hiroyuki Takamatsu;Junichi Taki;Mitsuyoshi Tatsumi

  201
  Citations